3-[(1h-pyrazol-4-yl)oxy]pyrazin-2-amine compounds as HPK1 inhibitor and the use thereof
TW202633884APending Publication Date: 2026-08-16BEONE MEDICINES I GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115101537
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-08-23
- Filing Date
- 2021-09-29
- Publication Date
- 2026-08-16
Abstract
Disclosed herein is 3-[(1H-pyrazol-4-yl)oxy]pyrazin-2-amine compounds of Formula (I), or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising thereof. Also disclosed is a method of modulating, e.g., inhibiting or treating HPK1 related disorders or diseases including cancer by using the compound disclosed herein.
Need to check novelty before this filing date? Find Prior Art